GHTF SG 3 Final- Meeting Minutes June 7 to 11, 2010 Los Angeles, California, USA

Similar documents
Introduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair

Introduction of AHWP. IMDRF Stakeholder Meeting 25 March 2015

IMDRF Project: List of international standards recognized by IMDRF management committee members

Observers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X

Software Regulation and Validation

International Medical Device Regulatory Harmonization. Reality or Fantasy?

2015 Annual FDA Medical Device Quality System Data. Inspections, FDA Form 483 Observations, and Warning Letter Citations

IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH

International trend on medical device regulatory convergence

IVD Regulatory Update February 2015

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017

Summary 12 th GHTF Steering Committee Meeting

Inspections, Compliance, Enforcement, and Criminal Investigations

ICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY

Latham & Watkins Corporate Department

Received an RTA Deficiency List or AI Letter? Now What?

Compounded Sterile Preparations Pharmacy Content Outline May 2018

Consideration on Global Harmonization

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

Why do we need an addendum to ICH E6?

CENTRAL SERVICE (CS) PERSONNEL AND THEIR HEALTHCARE

Which QMS Standard should be chosen for the structural quality of a medical laboratory? Matthias ORTH

Produce Safety Educators Monthly Meeting #16 April 6, PM EDT

S ince its incorporation in January 1992, Clinical

BASINGSTOKE AND NORTH HAMPSHIRE HOSPITALS NHS FOUNDATION TRUST

Complaints Investigation and Review. Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018

Brachytherapy-Radiopharmaceutical Therapy Quality Management Program. Rev Date: Feb

COMMISSION IMPLEMENTING REGULATION (EU)

GLOBAL BIOANALYSIS CONSORTIUM on harmonization of bioanalytical guidance 2014, time for a status update

STANDARD OPERATING PROCEDURE

International Trend on Medical Device Regulatory Convergence

Pre-Submissions and Meetings with FDA Staff

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

Annex. Provisions on auditing notified conformity assessment bodies in the framework of Article 34 3 of the Agency Regulation 1

Update on FDA-EMA QbD Pilot

September 1, Comments on Draft Reportable Food Registry (RFR) Guidance; Docket No. FDA-2009-D-0260

RECOMMENDATIONS FOR ON-SITE VISITS BY PEERS AND SELECTION CRITERIA FOR ON-SITE VISIT PEER REVIEWERS

April 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals

ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan

Technical Position Paper

Renewal Inspection Report. Ninewells Hospital Date of Inspection: 13 May 2009 Date of Licence Committee: 12 August 2009

GOOD LABORATORY PRACTICES (GLP) OVERVIEW

THE PREVENTIVE CONTROLS RULES AND THE FSPCA

ACCREDITATION REQUIREMENTS

FDA's OMB supporting document for QSr recordkeeping, 7/20/01, page 1 of 7

Post Market Surveillance (PMS): National Competent Authority Report (NCAR) Exchange Programme under IMDRF

Feedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center

Health Information and Quality Authority Regulation Directorate

Clinical Research Seminar

DG(SANCO)/ MR

PRE-INSPECTION QUESTIONNAIRE INSTRUCTIONS

MEDICAL DEVICES SECTOR

ISO TC 130/WG11 Environmental Impact of Printed Products 3 rd meeting 23 April :00 18:00 Yogyakarta, Indonesia

3.3 Facilitate sharing and understanding of: Key nuclear environment, radiological, industrial, safety, health, security, safeguards

Content Sheet 11-1: Overview of Norms and Accreditation

Procedure for handling applications for authorisation and review reports under REACH

FDA Guidance Hot Topics: Pre-Submission Guidance Review AMDM Focus Meeting October 25, Elizabeth Hillebrenner, MSE OIR/CDRH/FDA

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

Simplified Standard Operating Procedures (SSOPs) for Level 3 Emergencies. Overview of Steps and Timelines GEC. Level 3 Emergency

Client Alert. European Commission Proposes Overhaul of EU Clinical Trials Legislation

CDRH Device Quality Update March 17, 2015

POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)

IAF Mandatory Document for the Application of ISO/IEC in Medical Device Quality Management Systems (ISO 13485)

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

FINAL DOCUMENT. Global Harmonization Task Force

Upward Mobility Support Service Without Care at Home Floor B1 The Arts Complex St Margaret's House 151 London Road Edinburgh EH7 6AE Telephone: 0131

Fort Devens EMS Environmental Management System

Guidance for applicants requesting scientific advice

Agenda Item 4: Status of implementation of the AFI IIM regional projects adopted by APIRG

Remediation, Resolution and Outcomes

GUIDELINES FOR CRITERIA AND CERTIFICATION RULES ANNEX - JAWDA Data Certification for Healthcare Providers - Methodology 2017.

NSF Dietary Supplement Complete Service Offering. Experts in supplement auditing, consulting, testing and training.

Report on APEC-Funded Medical Device Delegation Visit Program to Australia, and Canada and the United States

IEEE ISCAS Bid Packet Requirements and Timeline

Connie Hoy October 2013

Health Education Administration s Public Health Education Collaborative

Administrative Policies and Procedures. Policy No.: N/A Title: Medical Equipment Management Plan

STANDARDS Point-of-Care Testing

CEN Technical Committees Mode of operations

DOD Anti-Counterfeit Rule Requires Immediate Action --By Craig Holman, Evelina Norwinski and Dana Peterson, Arnold & Porter LLP

Corrective and Preventive Action Procedure

Quality Management Training for Blood Transfusion Services

FSMA User Guide. Food Safety Modernization Act Guide

Purnendu C. Vasavada, Ph.D. Coordinator, FSPCA

Post Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015

IAF Guidance on the Application of ISO/IEC Guide 61:1996

Food Standards Agency in Wales

FDA Information Day: who should attend. Detailed Update on the Latest Information for ICSR and IDMP. Individual Case Safety Reports

:,-, WARNING LETTER. Mr. Jean Claude Mas Chief Executive Officer Poly Implants Protheses, Sa 337 Avenue De Bruxelles La Seyne, Sur Mer France

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Applicant Showings & Los Angeles ACO Process Improvement Initiative

CQC Inpatient Survey Results 2015

Are You Ready for FSMA? Janet Raddatz VP Quality & Food Safety Systems Sargento Foods Inc. WAFP June 12, 2013

1. Introduction. 2. Definitions. 3. Description of the evaluation procedure

APEC Subcommittee on Standards and Conformance

REPORT FROM SUB-COMMITTEE ON IMPLEMENTATION OF IMO INSTRUMENTS (III 4) SEPTEMBER 2017

PRIVATE WATER SUPPLIES STRATEGY FOR IMPROVEMENT A MULTI-AGENCY APPROACH

Transcription:

SG3 / N47 GHTF SG 3 Final- Meeting Minutes June 7 to 11, 2010 Los Angeles, California, USA Location 3M Unitek 2724 South Peck Road Monrovia California, USA 91016 Meeting objectives: 1) Review public comments on SG3(PD)N18 CAPA and prepare a Final version suitable for submission to SC 2) Continue design and development of SG3(Draft)N19 QMS deficiencies Meeting Agenda Topic 1 Welcome and Introductions (apologies/time/safety/lunch/admin support/other) Introduction of new permanent members, technical experts & observers 2 Acceptance of agenda 3 Review and accept minutes from April 8, 2010 teleconference. Review action items from Teleconference 4 SG3(PD)N18 Review public comments Prepare Final version of SG3 N18 5 Guidance document SG3(Working Draft) N19 Continue design and development activities 6 Feedback from SC meeting in Singapore May 10, 2010 SC ad hoc group on ISO 13485 New Chair for SG1 Other 7 Update on work of AHWP 8 Other Business Closing remarks SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 1 of 8

1) WELCOME AND INTRODUCTION The Chair opened the meeting at 9 am with logistical comments and welcome of members and observers. S Sardeson gave a 20 minute presentation about the history of 3M and the company s involvement in the medical device sector. Following the presentation 3M employees Ms Anne Wu and Mr Cisco Nuño gave the members a 30 minute guided tour of the 3M Unitek manufacturing facility. Attendees: Carlos Arglebe, Hideki Asai, E Cobbold, Ali al Dalaan, Emmett Devereux, Ron Goon, Laila Gurney, Kenichi Ishibashi, Taishi Nakashima, M Nakamura, Scott Sardeson, Dirk Wetzel, Kim Trautman, Observers: Victor Dorman-Smith, Hidetaka Hokao, Jerry Horn, Steve McRoberts, Julie Runge, Holly Seppanen Regrets: Gunter Frey (available by phone / webex for 1.5 days), Ken Nicol, Keith Smith Action Item 1-1: E Cobbold to update GHTF SG3 website with new member s name and titles. 2) ACCEPTANCE OF AGENDA The agenda was formally accepted with the addition of an item for E Cobbold and K Trautman to update the group on the work of ISO TC 176 on the revision to ISO 9001:2000. The update was performed under Other Business. 3) REVIEW AND ACCEPT MINUTES FROM APRIL 8, 2010 TELECONFERENCE The draft April 8, 2010 teleconference minutes were accepted as is. All action items were completed. Action Item 3-1 : E Cobbold to arrange to have teleconference minutes posted to GHTF website. 4 N18: Quality management system Medical Devices Guidance on corrective action and preventive action and related QMS processes Approximately 100 lines of public comments regarding the Proposed Draft version of N18 were reviewed. Changes were made to the draft text as appropriate. Where comments were not accepted, reasons were and will be provided to the commenter. Action Item 4-1: E Cobbold to provide feedback to those who submitted comments on PD N18. Action Item 4-2: Members are to review the final document by July 9th and provide E Cobbold with any additional comments. E Cobbold will submit the final document to the Steering Committee for the August 27th t-con. (Action completed. Final document submitted to SC on July 9, 2010) SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 2 of 8

5) BRAINSTORMING ON COMPOSITION OF N19 QUALITY MANAGEMENT SYSTEM MEDICAL DEVICES - CRITERIA FOR CHARACTERIZING THE SIGNIFICANCE OF QUALITY MANAGEMENT SYSTEM DEFICIENCIES The scope and intent of the document was reviewed then the Group brainstormed around developing a tool (Matrix) that could be used to rate the significance of nonconformities and the QMS audit as a whole. The group decided on a 4-point scale for assessment of risk where 1 is considered nonsignificant and 4 significant. A matrix was proposed and K Trautman, S McRoberts, S Sardeson and J Runge were tasked with providing the team members with a list of sanitized non-conformities to rate according to the matrix. The team will rate the non-conformances according to the matrix for a teleconference to be scheduled for September 16 th. The outcome of this teleconference will be used to help develop a first draft of the N19 guidance document at the meeting in Riyadh in October. To further illustrate the utility of a 4-point scale, the group conducted a brainstorming exercise (aka KJ Exercise) to develop examples of deficiencies related to QMS topics documentation and implementation of documents. Members identified four observations or fact that they considered to be deficiencies related to a QMS documentation requirement or the implementation of that QMS document. All deficiencies were allocated by the members into one of four groups depending on the member s expert opinion on the significance of the deficiency in relation to the QMS requirement. The output of the KJ exercise is in attachment 1. Action Item 5-1: K Trautman, S McRoberts, S Sardeson, J Runge to provide a list of sanitized nonconformities to rate according to the matrix by September 2 nd Action Item 5-2: From the list of QMS processes provided by S McRoberts members are to score their top 10 with Xs. Action Item 5-3: At the October meeting members are to take the examples that are provided in Item 5-2 then : 1) identify the nonconformity; 2) identify the process it belongs to from UL s list; and 3) grade the nonconformity from 1-4 (4 being the worse) under and Action Item 5-4: E Devereux, C Arglebe and D Wetzel to improve the LA version of N19 for use at the September teleconference/webex 6 FEEDBACK FROM SC MEETING IN SINGAPORE MAY 10, 2010 RE: 1) SC AD HOC GROUP ON ISO 13485 AND 2) NEW CHAIR FOR SG1 E Cobbold gave a brief update on the work of the SC ad hoc group on the improvement of ISO 13485. All SG3 members felt that SG3 should prepare a memo for the SC highlighting the work that SG3 has done with ISO TC 210 and the need for SG3 to continue its work with ISO TC 210/WG1. The memo was also to present a strategy for the revision of ISO 13485:2003 based on events currently taking place at ISO at the Technical Management Board (TMB) level and by the SC ad hoc group, lead by Dr Neumann, on the "improvement of ISO 13485". The members of SG3 felt very strongly that any future revision to ISO 13485 must be carried out according to the mandate that SG3 has been given by the SC on this subject as well as any agreements the GHTF has established with ISO and its various technical committees like TC176. SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 3 of 8

The memo was to be sent to the Chair of the SC and the member of the ad hoc group as soon as possible. It was announced at the Singapore meeting that Dr Ginette Michaud (FDA) was stepping down as Chairperson of SG1 and will be replaced by Ms Nancy Shadeed (HC) as the new Chairperson of SG1. Action 8-1 : E Cobbold to send memo to Steering Committee and CC all members of SG3. (Action completed. Memo sent July 14, 2010) 7 UPDATE ON WORK OF AHWP A Dalaan gave an update on the work of the AHWP WP3. He informed the group that the Saudi FDA will be hosting an AHWP conference in Riyadh December 4 to 8, 2010. The members of SG3 are invited to attend the conference. D Wetzel volunteered to attend the meeting as an SG3 representative and to give an update on the work of SG3. Action 7-1 : E Cobbold to send a memo to Dirk Wetzel inviting him to speak on behalf of SG3 at AHWP meeting (Action completed. Memo sent June 18, 2010) 8) OTHER BUSINESS Members invited to comment on SG1 s guidance document on definition of medical device. Documents and request for comments e-mailed to SG3 members on June 1, 2010. Action 8-1 : Members to submit comments on SG1 guidance document to A Kent by September 17, 2010. 9) FUTURE MEETINGS WHEN WHERE WHAT September 16, 2010 Webex/Teleconference GE(Canada) to host 1 hr teleconference. Start time TBD October 6-20, 2010 Riyadh, Saudi Arabia GHTF SG3 meeting (hosted by SFDA) April 11-12, 2011 Tokyo, Japan Joint GHTF SG3 TC 210/WG1 April 13- TBD, 2011 Tokyo, Japan GHTF SG3 meeting (hosted by JFMDA/Hitachi) September TBD, 2011 Buc, France SG3 meeting (hosted by GE ) Action 9-1: L Gurney to organize t-con / webex for September 16 th. SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 4 of 8

Action 9-2: E Cobbold to send request to E Kimmelman and H Woehrle for joint meeting with TC210 WG1. (Action completed. Teleconference bwtween EC, EK, EH and HW held July 28, 2010 and agreement reached for a joint SG3/TC210 WG1 meeting in Tokyo April 11&12, 2011) Action 9-3: A Hadiki to send request to JFMDA to host joint meeting between SG3 and TC210 in April 2011. Action 9-4: T-con will be scheduled between Saudi and Japan date to be determined in Saudi. CLOSING REMARKS The Chair thanked all participants for their attendance and contributions. Gratitude was expressed to 3M Unitek for graciously hosting the meeting. Special recognition and thanks was expressed to Vicki Skidmore for her administrative support. **** Submitted August 27, 2010 **** SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 5 of 8

Attachment 1 N19 Deficiencies KJ Exercise Topic 1 2 3 4 Documentation IFU Colour of binder out of spec Process requirement Traceability of document Perfectly controlled Regulatory requirements Well and followed Detailed sterilization approved and in Calibration records do not include statement of traceabilty to NIST Revision control Procedure is obsolete QM out of date Revision has not been correctly done There is no revision control on No dated No revision number Awareness Uncontrolled document on shop floor No signed by appropriate manager Not available in all languages required by users No copies on site for calibration performed by external firm No awareness of document but document does exist Implementation place Full Document is not controlled Documents are reviewed but not implementation No history record followed the inc all definition No tracecability SOP and Revision control Not available at responsibilities Wrong document point of use control number Procedure does Uncontrolled not reflect actual documents process IFU version number wrong Approval No approval by relevant key approvers Documents are not reviewed Procedure exists but not approved by required functions Internal audit not signed off QM Manual not signed Detailed sterilization in Detailed in place but non critical steps not carried out as Procedure does not outline roles and responsibilities There are no justifications for not to validate Document Clarity Unclear instructions White out and record keeping Record with missing data elements No No at all No at all No No No documentation or rule No incoming inspection records No records of process parameters of sterilization No documents No content Procedure does not exist No sterilization documentation in place Internal audit not No QM No medical device operation and control documentation Requirement Procedure does not address/reference regulatory requirements Pre-filled records Parking Lot No IFU for device No intended use in IFU SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 6 of 8

Topic 1 2 3 4 place but missing some minor sign offs Record clearly documents out of specification or Outside acceptance criteria with no justification for acceptance Record only Pass for measured inspection Procedure is in conflict with other procedural aspects on timelines Procedure that use terminology such as When appropriate or When needed Implementation Sterilisation fully, followed and fully meets all requirements Packing of device with accessories with wrong accessories in 0.5% of shipments QM not available on site Procedure is consistently applied meeting requirements with all required records. No anomalies detected Perfectly according to the Implemented completely Training complete and effective Procedure mostly applied well with isolated anomalies Implemented but a little differently from the Implemented but not consistent Management not available for audit Records are created but are not kept well. Some records are lost Employee contradicts No training schedule for the year Training programme does not include effectiveness evaluation Sterilisation fully, not fully followed by Quality objects are not revised for 5 years 50% of internal audits not performed Electronic record keeping is not validated Procedure understood by some operators Implemented but significantly different from the Sterilisation fully, not fully followed or used by operators and no process issues Calibration not performed over range of use Training complete but not effective several issues Process not followed completely Procedure does not address key measuring stages of a process leading to out of specification product CAPA was not reported to Top Management No management review record 50% of products not clean No implementation Procedure exists but there was no user training so it is not Only a subset of users are trained so is not consistently/always Change in critical process manufacturing condition (e.g. speed or temperature) not validated 50% of incoming inspection not performed Failure investigation not finding root cause SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 7 of 8

Topic 1 2 3 4 all but no process issues The contents of management review are not fully covered Training occurs after optional requirement Process followed completely but training not Procedure but no at point of use Process measuring does not address key risks of the process Procedure written but not followed correctly Only one site oot of a 4 site organization uses Computer system used to prevent release of non-conforming material is not validated Procedure written but operators not trained Risk analysis tools utilized to justify taking no actions versus predetermined trigger point or action levels Major design input specification not verified or validated Process not followed completely mandatory requirement Lack of implementation cause recall or field action Sterilization fully, not understood or followed, numerous issues No implementation Checklist not SG3 Los Angeles minutes 2010 06 Final N47 web.doc Page 8 of 8